SUDBURY, ON / ACCESSWIRE / February 28, 2018 / Northern Superior Resources Inc. (“Northern Superior” or the “Company”) (TSX-V: SUP) (OTCQB: NSUPF), is pleased to announce that it will be participating in a number of events during the Prospectors and Developers Conference (PDAC) held from March 2 – 7, 2018.

These include:

Corporate Presentation at the Red Cloud Pre-PDAC Showcase conference being held at the Adelaide Hotel in Toronto, 325 Bay Street, Friday March 2, 2018;
Dr. T.M. Morris will be presenting an invited lecture at the PDAC, “Exploration Geochemistry: Fundamentals and Case Histories”, Short Course, March 3, 2018;
Northern Superior will host a booth at the Investors Exchange Hall, Booth Number 3148, March 4 to 7, 2018; and
Participating with the PDAC 1 on 1 meeting program, March 6 and March 7, 2018.

We invite you to stop by our exhibit booth during the conference to learn more about Northern Superior. Management of Northern Superior will be available to answer your questions and explain the Company’s ongoing exploration programs. We look forward to seeing you there.

About Northern Superior Resources Inc.

Northern Superior is a reporting issuer in British Columbia, Alberta, Ontario and Québec, and trades on the TSX Venture Exchange under the symbol SUP, and on the OTCQB Venture Market under the symbol NSUPF. The Company is currently focused on exploring its 100% owned Croteau Est (Québec) and Ti-pa-haa-kaa-ning (Northwestern Ontario) properties. The Company’s remaining properties (all 100% owned) in Québec and Northwestern Ontario are available for option.

For further information please visit the Company’s website at www.nsuperior.com or contact:

Thomas F. Morris P.Geo., PhD., FGAC
President and CEO
Tel: (705) 525 ‐0992
Fax: (705) 525 ‐7701
e‐mail: info@nsuperior.com
www.nsuperior.com

SOURCE: Northern Superior Resources Inc.

ReleaseID: 490802

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of ProGreen Properties Inc. (OTCQB: PGUS) and Computer Services Inc. (OTCQX: CSVI), including recent technical analysis and consolidated fundamental information.

Growth Market Report Initiates Coverage on:

PGUS DOWNLOAD: http://GrowthMarketReport.com/signup/?co=PGUS
CSVI DOWNLOAD: http://GrowthMarketReport.com/signup/?co=CSVI

ProGreen Properties Inc. (PGUS) REPORT OVERVIEW

On February 26th, 2018, ProGreen Properties Inc. closed out the trading session at $0.02 (down 8.26%), compared to the previous day close of $0.0218. The volume on the day was 628,978 (down 64.33%), compared to the company’s previous day volume of 1,763,329. For the twelve months ended April 30th, 2017 vs April 30th, 2016, ProGreen Properties reported revenue of $0.07MM vs $0.21MM (down 65.13%) and basic earnings per share $0.00 vs $0.00. ProGreen Properties is expected to report earnings on March 20th, 2018, the report will be for the fiscal period ending January 31st, 2018.

Access Growth Market Report’s ProGreen Properties Inc. Research Report at http://GrowthMarketReport.com/signup/?co=PGUS

Computer Services, Inc. (CSVI) REPORT OVERVIEW

Computer Services’ Recent Financial Performance

On February 26th, 2018, Computer Services, Inc. closed out the trading session at $44.81 (up 0.58%), compared to the previous day close of $44.55. The volume on the day was 1,808 (down 68.83%), compared to the company’s previous day volume of 5,801. For the twelve months ended February 28th, 2013 vs February 29th, 2012, Computer Services reported revenue of $198.26MM vs $178.22MM (up 11.24%) and basic earnings per share $1.76 vs $1.74 (up 1.15%). Computer Services is expected to report earnings on March 1st, 2018, the report will be for the fiscal period ending November 30th, 2017.

Access Growth Market Report’s Computer Services, Inc. Research Report at http://GrowthMarketReport.com/signup/?co=CSVI

Our Actionable Research on ProGreen Properties Inc. (OTCQB: PGUS) and Computer Services, Inc. (OTCQX: CSVI) can be downloaded free of charge at http://GrowthMarketReport.com/.

ABOUT Growth Market Report

It’s no secret that Wall Street analysts spend the lion’s share of their time focused on large, well-known companies and securities—they make most of their money from investment banking. As a result, small-cap companies are relatively underserved when it comes to top-quality research and analysis. Growth Market Report was developed to fill in that gap.

DISCLAIMER

Growth Market Report is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at http://GrowthMarketReport.com/.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by Growth Market Report. Growth Market Report is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

Growth Market Report, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. Growth Market Report, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, Growth Market Report, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither Growth Market Report nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

MEDIA CONTACT:

Jack Sutherland,
Media Department
Office: +1 (205) 217-4026
E-mail: media@GrowthMarketReport.com

SOURCE: Growth Market Report

ReleaseID: 491125

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Vitality Biopharma, Inc. (OTCQB: VBIO) and Growlife, Inc. (OTC PINK: PHOT), including recent technical analysis and consolidated fundamental information.

Growth Market Report Initiates Coverage on:

VBIO DOWNLOAD: http://GrowthMarketReport.com/signup/?co=VBIO
PHOT DOWNLOAD: http://GrowthMarketReport.com/signup/?co=PHOT

Vitality Biopharma, Inc. (VBIO) REPORT OVERVIEW

On February 26th, 2018, Vitality Biopharma, Inc. closed out the trading session at $2.00 (up 0.50%), compared to the previous day close of $1.99. The volume on the day was 133,365 (up 83.32%), compared to the company’s previous day volume of 72,751. For the twelve months ended March 31st, 2017 vs March 31st, 2016, Vitality Biopharma reported revenue of $0.16MM vs $0.25MM (down 34.19%) and basic earnings per share -$0.38 vs -$0.02. Vitality Biopharma is expected to report earnings on February 27th, 2018, the report will be for the fiscal period ending December 31st, 2017.

Access Growth Market Report’s Vitality Biopharma, Inc. Research Report at http://GrowthMarketReport.com/signup/?co=VBIO

Growlife Inc. (PHOT) REPORT OVERVIEW

Growlife’s Recent Financial Performance

On February 26th, 2018, Growlife, Inc. closed out the trading session at $0.0161 (down 6.94%), compared to the previous day close of $0.0173. The volume on the day was 13,466,578 (down 10.86%), compared to the company’s previous day volume of 15,107,545. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Growlife reported revenue of $1.23MM vs $3.50MM (down 64.82%) and basic earnings per share -$0.01 vs -$0.01. Growlife is expected to report earnings on March 30th, 2018, the report will be for the fiscal period ending December 31st, 2017.

Access Growth Market Report’s Growlife, Inc. Research Report at http://GrowthMarketReport.com/signup/?co=PHOT

Our Actionable Research on Vitality Biopharma, Inc. (OTCQB: VBIO) and Growlife Inc. (OTC PINK: PHOT) can be downloaded free of charge at http://GrowthMarketReport.com/.

ABOUT Growth Market Report

It’s no secret that Wall Street analysts spend the lion’s share of their time focused on large, well-known companies and securities—they make most of their money from investment banking. As a result, small-cap companies are relatively underserved when it comes to top-quality research and analysis. Growth Market Report was developed to fill in that gap.

DISCLAIMER

Growth Market Report is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at http://GrowthMarketReport.com/.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by Growth Market Report. Growth Market Report is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

Growth Market Report, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. Growth Market Report, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, Growth Market Report, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither Growth Market Report nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

MEDIA CONTACT:

Jack Sutherland,
Media Department
Office: +1 (205) 217-4026
E-mail: media@GrowthMarketReport.com

SOURCE: Growth Market Report

ReleaseID: 491126

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / INNODATA INC. (NASDAQ: INOD) today announced that it will report fourth quarter and fiscal year 2017 results before the market opens on Thursday, March 8, 2018. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com.

Innodata has scheduled an investor conference call for 11:00 AM eastern time on that same day.

The call-in numbers for the conference call are:

1-800-289-0438 (Domestic)
1-323-794-2423 (International)

1-888-203-1112 (Domestic Replay)
1-719-457-0820 (International Replay)

Passcode on both: 1067298

Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of www.innodata.com. Please note that the Webcast feature will be in listen-only mode.

Call-in or Webcast replay will be available for 30 days following the conference call.

About Innodata

Innodata (NASDAQ: INOD) is a global digital services and solutions company. Innodata’s technology and services power leading information products and online retail destinations around the world. Innodata’s solutions help prestigious enterprises harness the power of digital data to re-imagine how they operate and drive performance. Innodata serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies and many other industries.

Founded in 1988, Innodata comprises a team of 4,000 diverse people in 8 countries who are dedicated to delivering services and solutions that help the world’s businesses make better decisions.

Innodata honors include EContent Magazine’s EContent 100, KMWorld Magazine’s 100 Companies That Matter in Knowledge Management, the International Association of Outsourcing Professionals’ (IAOP) Global Outsourcing Top 100, D&B India’s Leading ITeS and BPO Companies and the Black Book of Outsourcing’s Top List of Leading Outsourcing Providers to the Printing and Publishing Business.

Forward-Looking Statement

This release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “project,” “head start,” “believe,” “expect,” “should,” “anticipate,” “indicate,” “point to,” “forecast,” “likely,” “goals,” “optimistic,” “foster,” and other similar expressions generally identify forward-looking statements, which speak only as of their dates.

These forward-looking statements are based largely on our current expectations and are subject to a number of risks and uncertainties, including without limitation, that contracts may be terminated by clients; projected or committed volumes of work may not materialize; the primarily at-will nature of contracts with our Digital Data Solutions clients and the ability of these clients to reduce, delay or cancel projects; continuing Digital Data Solutions segment revenue concentration in a limited number of clients; continuing Digital Data Solutions segment reliance on project-based work; inability to replace projects that are completed, canceled or reduced; our dependency on content providers in our Media Intelligence Solutions segment; difficulty in integrating and deriving synergies from acquisitions, joint venture and strategic investments; potential undiscovered liabilities of companies and businesses that we may acquire; potential impairment of the carrying value of goodwill and other acquired intangible assets of companies and businesses that we acquire; changes in our business or growth strategy; depressed market conditions; changes in external market factors; the ability and willingness of our clients and prospective clients to execute business plans which give rise to requirements for our services; changes in our business or growth strategy; the emergence of new or growing competitors; various other competitive and technological factors; and other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission.

Our actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements will occur.

We undertake no obligation to update or review any guidance or other forward-looking information, whether as a result of new information, future developments or otherwise.

Company Contact

Raj Jain
Vice President
Innodata Inc.
rjain@innodata.com
(201) 371-8024

SOURCE: Innodata Inc.

ReleaseID: 490738

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Analog Devices, Inc. (NASDAQ: ADI) will be discussing their earnings results in their Q1 Earnings Call to be held on February 28, 2018 at 10:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23318.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490914

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Novanta Inc. (NASDAQ: NOVT) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018, at 10:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/24272.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490918

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / TravelCenters of America LLC (NASDAQ: TA) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018, at 10:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/2236.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490919

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Lipocine shares were on fire after receiving an upgrade and a price target of $21 a share. Shares of DelMar Pharmaceuticals also soared higher despite any news but a report indicated the company has been granted a U.S. patent related to its VAL-083 drug candidate.

RDI Initiates Coverage on:

Lipocine Inc.
https://rdinvesting.com/news/?ticker=LPCN

DelMar Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=DMPI

Lipocine’s shares were on fire in Tuesday trading, closing the day up 16.03% on high volume. The stock traded roughly 5.5 million shares compared to an average of a little under 550,000 shares. The stock was upgraded by Dr. Cathy Reese of Empire Asset Management to “Buy” from “Hold” and was given a $21 price target. Traders were encouraged by her upgrade considering that the stock is down nearly 57% since the FDA’s Bone, Reproductive, and Urologic Drugs Advisory Committee voted 6-13 on Tlando’s benefit-risk profile. Tlando is an oral product candidate for testosterone replacement therapy. Reese remarked, “We believe that Tlando has a high probability of gaining an approval, whether it is on the PDUFA date or once the blood pressure and collection test tube clinical data is generated and reviewed, which we believe should occur in 2018.”

Access RDI’s Lipocine Inc. Research Report at:
https://rdinvesting.com/news/?ticker=LPCN

DelMar Pharmaceuticals’ shares closed up 13.59% yesterday on almost 4.9 million shares traded. The stock was exploding despite any remarkable news from the company but a Benzinga article reported that the company has been granted U.S. patent related to its VAL-083 drug candidate. It was two months ago that DelMar soared 40% when it announced that its lead-product cancer treatment, VAL-083, was granted “Fast Track” designation by the FDA. Interim CEO Saiid Zarrabian stated at the time, “We are enthusiastic about the potential of VAL-083 to offer a meaningful clinical benefit to patients with rGBM and for the opportunity to expedite the regulatory process through the FDA’s Fast Track program.” The drug is a potential new treatment for a recurrent cancer of the brain and spinal cord called glioblastoma (rGMBM).

Access RDI’s DelMar Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DMPI

Our Actionable Research on Lipocine Inc. (NASDAQ: LPCN) and DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 491179